small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search
  • Professionals (544)
  • Capabilities (88)
  • Experience (300)
  • Insights & News (5,226)
  • Other Results (107)

Professionals 544 results

David A. Sakowitz
David A. Sakowitz
Partner
  • New York, 
  • London
Email
+1 212-294-2639
vCard

Partner

  • New York
  • London
Michael J. Blankenship
Michael J. Blankenship
Partner
  • Houston, 
  • San Francisco , 
  • New York
Email
+1 713-651-2678
vCard

Partner

  • Houston
  • San Francisco
  • New York
Nicholas Usher
Nicholas Usher
Partner
  • London
Email
+44 20 7011 8734
vCard

Partner

  • London
View All Professionals

Capabilities 88 results

Practice Area

Capital Markets

Our capital markets and securities attorneys represent U.S. and international issuers, institutional investors, underwriters, and placement agents in a wide variety of public and private offerings of debt and equity securities....Read more

Practice Area

Private Equity

Winston & Strawn’s private equity attorneys provide strategic advice and legal counsel to middle-market private equity funds, hedge funds, family offices, real estate funds, alternative asset managers, portfolio companies, and institutional investors. We have one of the broadest and most active national middle-market private equity practices in the U.S. ...Read more

Practice Area

Secondaries & Liquidity Solutions

Winston & Strawn’s Secondaries and Liquidity Solutions group delivers market-leading counsel to clients navigating the evolving landscape of private fund liquidity, secondaries transactions, and bespoke capital solutions. Our multidisciplinary team advises private fund sponsors, institutional investors, and asset managers on the full spectrum of private investment fund secondary market activity, from traditional LP portfolio sales to complex GP-led transactions and innovative liquidity structures. Our attorneys are consistently recognized by leading private equity corporate publications, including Chambers, Legal 500, and others....Read more

Experience 300 results

Experience

|

November 19, 2025

Blockfusion Enters into Business Combination with Blue Acquisition Corp.

Winston & Strawn LLP represents Blockfusion, the owner-operator of a strategically located, clean-energy-powered data center, in its announced business combination with Blue Acquisition Corp., a publicly traded special purpose acquisition company. The transaction attributes a pre-money equity value of approximately USD 450 million to Blockfusion and would result in Blockfusion becoming a publicly traded company upon listing....Read more

Experience

|

October 24, 2025

$400 Million GATX Corporation Senior Notes Offering

Represented joint book-running managers BofA Securities, Inc., Citigroup Global Markets Inc., and Morgan Stanley & Co. LLC, as underwriters' counsel, in connection with the registered public offering by GATX Corporation of $200 million of its 5.500% Senior Notes due 2035 and $200 million of its 6.050% Senior Notes due 2054. ...Read more

Experience

|

October 10, 2025

Winston Advises Vistria Affiliate in $136M IPO of Phoenix Education Partners

A Winston & Strawn LLP team led by partners Keerthika Subramanian, Steve Gavin and Timothy Kincaid and including Jacob Tabman, Jeremy Spankowski and Jenna Smith advised TVG-I-E-AEG Holdings, LP, an affiliate of The Vistria Group, as one of the selling stockholders in the $136 million initial public offering of Phoenix Education Partners, Inc. (NYSE: PXED), the parent company of The University of Phoenix, Inc. The IPO valued Phoenix Education Partners, Inc. at approximately $1.35 billion. The transaction marks The University of Phoenix’s return to public markets after nearly a decade as a private company....Read more
View All Experience

Insights & News 5,226 results

Webinar

|

December 17, 2025

Privacy Problems Webinar Series

Join the Winston & Strawn Global Privacy and Data Security Practice team for a conversation on emerging privacy trends to have on your radar as we approach the New Year. Topics will include a discussion of strategies companies can take to protect themselves against a wave of burgeoning claims under California’s Shine the Light Law, recent trends in wiretap lawsuits arising from online website monitoring and email tracking practices (hint: looking at you, Florida), and insights on why companies should pay close attention to commercial email subject lines sent to Washington recipients....Read more

Sponsorship

|

December 8, 2025

Winston & Strawn Sponsors REITworld 2025 Annual Conference

Winston & Strawn is proud to sponsor the upcoming REITworld Annual Conference. The conference connects more than 1,000 REIT executives and investors to discuss company performance and investment opportunities for the year ahead. ...Read more

The Reg E Reader

|

December 3, 2025

|

5 Min Read

The Status of The CFPB: A Year-End Review

The Reg E Reader features insights from Winston & Strawn’s multidisciplinary Consumer Financial Services Group on legal and enforcement developments related to Regulation E. The blog provides guidance and best practices for those who must remain compliant with the complex, evolving requirements of the regulation. In this blog post, Caitlin Mandel, Arman Aboutorabi, and Sydney Alexandra Rose provide a year-end review on the status of the CFPB, highlighting recent news, rulemaking activities, and hints toward the agency's future heading into 2026.

View All Insights & News

Other Results 107 results

Law Glossary

What Is Consumer Marketing Law?

Consumer marketing law is a broad legal segment dealing with federal and state statutes, along with government regulations, established to ensure that marketing and advertising are truthful. Federal law states that no form of advertising, including online advertising, can be deceptive. Marketing claims must also be evidence-based....Read more

Law Glossary

What Statutes and Regulations Govern the Approval and Marketing of Biosimilars?

Congress passed the Biologics Price Competition and Innovation Act of 2009 (BPCIA) in 2010 an amendment of the Public Health Services Act. The BPCIA is codified at 42 U.S.C. § 262....Read more

Site Content

Public Company Gateway

Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2025. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising